Executive Order Would Tie U.S. Drug Prices to What Other Countries Pay
News & Updates from McGivney Global
- Oct 11, 2018
- 1 min
Collaboration with McGA achieves NCCN Preferred positioning
- Aug 24, 2018
- 3 min
CMS Allows MA Plans to Apply Step Therapy to Part B Drugs in 2019
- Jun 29, 2018
- 2 min
Operational Implementation of CAR-T Cell Therapy
- Jun 21, 2018
- 2 min
Webinar: What Biotech and Pharma execs need to know about blockchain
- May 24, 2018
- 1 min
Free Webinar: Is CAP Coming Back?
- May 24, 2018
- 2 min
40 Under 40 in Cancer: Congratulations Awardees!
- Apr 3, 2018
- 2 min
MedPAC, MIPS, and the Tenacity of Fee-for-Service
- Feb 15, 2018
- 2 min
RE: Alphabet-Backed Flatiron Health is Being Acquired by Roche
- Oct 5, 2017
- 3 min
More NCCN Categories Bring Inconsistency, Uncertainty, and Consternation
- Oct 25, 2016
- 1 min
Oncologists, McGivney Weigh in on Value Frameworks
- Oct 25, 2016
- 2 min
Comments on the Recent Institute for Clinical and Economic Review (ICER) Meeting
- Jul 11, 2016
- 1 min
Impact of Oncology Value Metrics
- Jul 8, 2016
- 4 min
Health Insurers Behaving Badly...
- Jun 28, 2016
- 6 min
Life, Death, and Money: The Hidden Economics of Cancer
- Jun 16, 2016
- 1 min
McGA work on ICER cited by BIO
- Apr 18, 2016
- 2 min
RE: ICER to Evaluate Value of Amgen's Multiple Myeloma Treatment
- Mar 16, 2016
- 5 min
How Medicare is Gambling with Cancer Care